PATENT CLAIM ANALYSIS

Application Number: 15968227
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-08
Patent Classification: ["548", "201000"]

Abstract:
Provided are a xanthine oxidase inhibitor, a drug for improving vascular endothelial function, and an excellent therapeutic or prophylactic drug for diseases associated with xanthine oxidase such as gout, hyperuricaemia, and for diseases associated with vascular endothelial functional disorder containing a compound represented in a formula (I) or the pharmaceutically acceptable salt thereof as an active ingredient.

Claim (Index 11):
The method according to  claim 10 , wherein R 2  is a methyl group.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 93.0
- Lexical Diversity: 1.45455
- Patent Class: 548.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14442752', '11661284', '11661294', '14349201', '15424075']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.766363226393463
- 35 USC 102 Novelty (BERT): 0.5396909035260176
- Combined Prediction Score: 0.7436959941067185
- Mean Citation Score: 301.764414
- Max Citation Score: 375.76303
- Similarity Product: 261.5467618071014

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test